Sign inJoin waitlistJoin the waitlist

Robert Lowsky

Director, Apheresis Unit, Blood and Marrow Transplantation, Stanford University · Stanford Health Care

Credentials: · ·

History

Toronto General Hospital Postgraduate Education (1989) Canada
1991–1993
Toronto General Hospital Postgraduate Education (1989) Canada
1990–1993
Toronto General Hospital Postgraduate Education (1989) Canada
1989–1991
Toronto General Hospital Postgraduate Education (1989) Canada
1986–1989
MCGILL UNIV, MONTREAL
1984–1988

Research

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Nature Medicine · 2021 · 534 citations
Tolerance and chimerism after renal and hematopoietic-cell transplantation
Case report · New England Journal of Medicine · 2008 · 414 citations
Protective conditioning for acute graft-versus-host disease
New England Journal of Medicine · 2005 · First of 14 authors · 252 citations

Judith Shizuru
50 papers
Robert Negrin
48 papers
Laura Johnston
46 papers
Sally Arai
45 papers
David Miklos
44 papers
Wen-Kai Weng
38 papers
Everett Meyer
34 papers
Lori Muffly
33 papers
Andrew Rezvani
32 papers
Parveen Shiraz
25 papers
Matthew Frank
24 papers · 1 as a fellow
SS
Samuel Strober
24 papers · 5 as a fellow

Grants

Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
National Cancer Institute · P01
Project lead · $4.5M · Stanford University
1997–2025
BMT Core - Stanford University
National Heart, Lung, and Blood Institute · UG1
Contact PI · $726.8K · Stanford University
2001–2024
BMT Clinical Trial Network at Stanford
National Heart, Lung, and Blood Institute · U10
Contact PI · $269.1K · Stanford University
2001–2017
Blood Stem Cell Transplantation as Immunotherapy
National Heart, Lung, and Blood Institute · P01
Project lead · $1.3M · Stanford University
2004–2016

Clinical trials

Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment
Principal investigator · Recruiting · Phase 1
Stanford University
2022–2029
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML
Principal investigator · Completed · Phase 2
Robert Lowsky
2020–2023
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
Principal investigator · Completed · Phase 2
Stanford University
2018–2020
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
Principal investigator · Completed · Phase 2
Robert Lowsky
2015–2021